Findings

What do systematic reviews say?

7 questions · 7 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 3 · 42.9%Moderate 4 · 57.1%High 0 · 0%

Regular salmeterol vs salbutamol

All‐cause non‐fatal serious adverse events ‐ adults and adolescents · patients with chronic asthma

Regular salmeterol showed no clear difference in all‐cause non‐fatal serious adverse events ‐ adults and adolescents compared with regular salbutamol (moderate certainty).

1 finding from 1 review

Regular treatment with salmeterol for chronic asthma: serious adverse events 2008 · Cochrane Headline outcomes only
OR 0.96 [0.85, 1.1]
5 studies · 27002 participants
Moderate

Regular salmeterol vs salbutamol

All‐cause non‐fatal serious adverse events ‐ children · patients with chronic asthma

Regular salmeterol showed no clear difference in all‐cause non‐fatal serious adverse events ‐ children compared with regular salbutamol (moderate certainty).

1 finding from 1 review

Regular treatment with salmeterol for chronic asthma: serious adverse events 2008 · Cochrane Headline outcomes only
OR 1.37 [0.71, 2.64]
3 studies · 1181 participants
Moderate

Regular salmeterol vs salbutamol

Asthma‐related mortality ‐ adults and adolescents · patients with chronic asthma

Regular salmeterol showed no clear difference in asthma‐related mortality ‐ adults and adolescents compared with regular salbutamol (moderate certainty).

1 finding from 1 review

Regular treatment with salmeterol for chronic asthma: serious adverse events 2008 · Cochrane Headline outcomes only
OR 2.36 [0.78, 7.16]
4 studies · 26463 participants
Moderate

Regular salmeterol vs salbutamol

Asthma‐related non‐fatal serious adverse events ‐ adults and adolescents · patients with chronic asthma

Regular salmeterol showed no clear difference in asthma‐related non‐fatal serious adverse events ‐ adults and… compared with regular salbutamol (low certainty).

1 finding from 1 review

Regular treatment with salmeterol for chronic asthma: serious adverse events 2008 · Cochrane Headline outcomes only
OR 0.94 [0.37, 2.34]
3 studies · 1155 participants
Low

Regular salmeterol vs salbutamol

Asthma‐related non‐fatal serious adverse events ‐ children · patients with chronic asthma

Regular salmeterol showed no clear difference in asthma‐related non‐fatal serious adverse events ‐ children compared with regular salbutamol (low certainty).

1 finding from 1 review

Regular treatment with salmeterol for chronic asthma: serious adverse events 2008 · Cochrane Headline outcomes only
OR 1.04 [0.47, 2.31]
3 studies · 1186 participants
Low

Regular salmeterol vs salbutamol

All‐cause mortality ‐ adults and adolescents · patients with chronic asthma

Regular salmeterol showed no clear difference in all‐cause mortality ‐ adults and adolescents compared with regular salbutamol (moderate certainty).

1 finding from 1 review

Regular treatment with salmeterol for chronic asthma: serious adverse events 2008 · Cochrane Headline outcomes only
OR 1.28 [0.79, 2.05]
4 studies · 26463 participants
Moderate

Regular salmeterol vs salbutamol

All‐cause mortality ‐ children · patients with chronic asthma

Regular salmeterol showed no clear difference in all‐cause mortality ‐ children compared with regular salbutamol (low certainty).

1 finding from 1 review

Regular treatment with salmeterol for chronic asthma: serious adverse events 2008 · Cochrane Headline outcomes only
OR 0.04 [0, 2.97]
3 studies · 1152 participants
Low